Endoscopic sinus surgery in patients who have an Onodi cell (sphenoethmoid cell) carries a high risk f or optic nerve injury. We meticulously dissected 65 embalmed cadaver adult half-heads and attempted to identify an optic canal bulge in each with a nasal endoscope. Our aims were to determine the prevalence ofan Onodi cell in adult Thai cadavers, to ascertain the prevalence of an overriding ethmoid cell, and to measure the length ofan overriding ethmoid cell's superio r and posterior extensions in relation to the anterior sphenoid wall. Moreover, we attempted to determine the minimum amount ofbone thickness betwee n an Onodi cell and the optic nerve. We fo und that an Onodi cell was present in 39 of the 65 specimens (60.0 %). We also fo und that an overriding ethmoid cell was present in 14 spec imens, which accounted f or 21.5 % of the total numb er of specimens and 36.8% of38 Onodi cell-pos itive speci mens (the presence or absence of an overriding ethmoid cell was not recorded in one of the 39 Onodi cell-pos itive specimens). The distance of the overriding ethmoid cell 's superior and posterior extensions f rom the anterior sphenoid wall rangedfro m 3 to 13 mm (median: 7) andfrom 4 to 16mm (median: 9.5), respectively. Measurements of the minimum amount ofbone thicknesses between each Onodi cell and optic nerve ranged fro m 0.03 to 0.54 mm (median: 0.08). Our study demonstrated that the prevalence ofan
Introduction
Endo scopic sinus surgery is widely used for the management of rhinosinusitis and nasal polyps. With a nasal endoscope, the surgeon can see the oper ative field , lateral nasal wall, and paran asal sinuses more clearly than is possible with the con ventional headli ght-and-speculum surgical techn ique. Neverthel ess, major orbital and intracranial complications of endoscopic sinus surgery have been reported. ':"
Orbital complications are serious, and they can lead to blindn ess, particularly when the optic nerve is injured . Maniglia reported three cases of permanent blindness following intranasal ethmoidectomy.' Buus et al reported the case of a patient who se optic nerve s on both sides were severed during an intranasal ethmoidectomy.' The risk of optic nerve injury during sinus surgery is increased when the procedure is perfo rmed on the posterior ethmoid and sphenoid sinuses.t' -'? During such surger y, the posteriormost ethmoid air cell can undergo extensive pneumatization and come into close contact with or encroach on the optic canal, thus cre ating an Onodi cell (sphenoethmoid cell)." An Onodi cell is defined as the posteriorm ost ethmoid cell that features an endoscopically identifiable bulge in the optic canal, even if it is minim al." Patients who have an Onodi cell are also at increased risk for optic nerve injury during endoscopic sinus surgery .
The prevalence of Onodi cells varies greatly. The only previous gross anatom ic dissection study of the prevalence of Onodi cells in Asia was conducted in Singap ore by Yeoh and Tan. 12 They studied 102 half-heads from 51 cadavers and found an Onodi cell in 52 half-heads (5 1.0%), An Onodi cell was found bilaterally in 44 half-he ads (43,1%) and unilaterally in eight (7.8%). Therefore, at least one Onodi cell was found in 30 of the 51 whole heads, fora prevalence of58. 8 
Resu lts
We studied 30 right-sided and 35 left-sided half-head specimens. An Onodi cell was found in 39 of the 65 specimens (60.0%; 90% CI: 49 to 70%). There was no clinically or statis tically significant difference in prevalence between male and fema le specimens or right-and left-sided specimens (table 1) . An overriding ethmoid cell was found in only L4 specimens, which accounted for 21.5 % of the total number of 65 specimens (90% CI: 14 to 32%) and 36.8% of38 Onodi cell-positive specimens (90% CI: 24 to 51%) (the presence or absence of an overriding ethmoid cell was not recorded in one of the 39 Onodi cell-positive specimens).There was no overriding ethmoid air cell in any Onodi cell-negative specimen.
The 14 overriding ethmoid cells extended superiorly over the anterior walls of the sphenoid sinuses at a distance of between 3 and 13 mm (median 7; 25th percentile: 5; 75th our analysis, we selected 65 whole heads , which had been obtained from 46 male and 19 female cadavers . One-half of each head was randoml y selected for study. The age of the donors at the time of death ranged from 17 to 92 years (mean: 60). None of the donors had had a history of paranasal sinus disease or surgery during their lifetimes , and all had intact posterior ethmoid and sphenoid sinuses .
Each half-head was meticulously dissected for total ethmoidectomy with a drill and other instruments. A 30 0 nasal endoscope was used to search for an Onodi cell. All assessments of the presence or absence of an Onodi cell were performed independently by two physicians . We also measured the length of the superior and posterior extensions of the overriding ethmoid cell in relation to the anterior wall of the sphenoid sinus. When we did identify an Onodi cell, we carefully removed the medial wall of the optic canal (figure). We then measured the thickness of the removed bone at five randomly selected locations with a micrometer and recorded the thickness of the bone at its thinnest point.
We estimated that 65 specimens would provide a 90% confidence interval (CI) equal to the prevalence plus or minus 10% when the estimated prevalence was 59%, which was the rate reported by Yeoh and Tan. 12 Descriptive statistics were used for analysis. If the data showed a normal distribution, results were reported as point estimates with a 90% CI; if not, nonparametric statistics were used . Our study was approved by the ethics committee of Khon Kaen University.
Difference in CI* (90% CI) did not mention what selection criteria they used in choos ing their specimens.
In this article , we describe our study to determine the prevalence of an Onodi cell in adult Thai cadavers, to ascertain the prevalence of an overriding ethmoid cell, to measure the length of an overriding ethmoid cell 's superior and posterior extensions in relation to the anterior sphenoid wall, and to determine the minimum amount of bone thickness between each Onodi cell and optic nerve . 
Materials and methods
This cross-sectional descriptive study of embalmed heads was conducted by members of the Department of Otolaryngology and the Department of Anatomy at the Khon Kaen University Faculty of Medicine in Thailand between June 1997 and June 1998. The heads had been prepared to assist in the training of medical students. For Table 2 . Minimum w idth of bony th ickness between the Onodi cell and optic nerve in 31 specimens
Discussion
Sinus surgery patients who have an Onodi cell are at increased risk for optic nerve injury if the surgeon is not aware of the cell's presence. The previously reported prevalence of an Onodi cell varies greatly, ranging from 7 to 51 % (table 3) .11.12.14-19These variations might be attributable to (l) different operational definitions of an percentile: 10). They extended posteriorly at a distance of between 4 and 16 mm (median: 9.5; 25th percentile: 7; 75th percentile: 13).
The minimum amount of bone thickness between an Onodi cell and optic nerve was measured in 31 of the 39 Onodi cell-posi tive specimens (eight measurements were not taken because the bones had broken during removal) ( Onodi cell , (2) different samp ling techniques, (3) racial factors, and (4) differences in examination methods (e.g., observations based on endoscopic or gross anatomic dissection or computed tomography [CT]). With respect to examination methods, nasal endoscopy should be more sensitive than CT in identifying an Onodi cell because the optic canal can be magnified and visualized directly.' ? In fact, authors who have used an endoscope to look for an Onodi cell have consistently found higher prevalence rates than have those who used CT, even in Asians (table 3) . For example, Aibara et al in Japan based their prevalence study on CT of live subjects rather than gross anatomic dissection of cadaver specimens , and they found a prevalence of only 7% . 16 Although optic nerve injury is the most serious surgical risk in patients with an Onodi cell , there are other risks to vision, as well. Weinberger et aP4 reported two cases of Onodi cell sinusitis, and Ogata et aForeported one case of retrobulbar optic neuropathy that occurred in an isolated mucocele in an Onodi cell.
Only one previous study has reported the prevalence of an overriding ethmoid air cell; in the United States, Bansberg et al reported a prevalence of 8% based on their CT examinations." The prevalence in our study was much higher (21.5 %). Again, the disparity in these findings migh t be attributable to our use of anatomic dissection rather than CT and perhaps to racial differences.
Also of note is our finding that an overriding ethmoid cell was present in more than one-third (36 .8%) of specimens that had an Onodi cell and in 0% of those that did not. We can conclude from this that any patient who has Rat Hep at ocyt eDNARepai r Assay Mi cronucleu s Test(Mi ce) Dominan t LethalTest (Mice) Long-t erm carci nogenicitystudiesin mi ceand rat s havebeencompleted for ciprolloxacin. After dail y oral doses 01750 mglkg (mice) and250 mglkg (rat s) were administered for upto 2 years, there was no evidence that ciprofloxacin hadany carcinogenicor tumorigenic effects inthese species. No long term studiesof CIPRO' HC OTIC suspension have beenperformedto evaluatecarcinogenicpotent ial. Fertility studies performed in rats at oral doses of ci prof loxacin up to 100 mglkglday revealed no evi dence 01impairment. This would be over 1000 times themaximum recommendedclinica l dose of ototopical ciprofloxacinbasedupon body surface area,assuming totalabsorptionof ciprofloxacin fromthe earof apatient treat edwith CIPRO' HCOTICtwiceperday. Long term studies have not been performed to evaluate the carcinogenic potential or the effect on fertilityof topical hydrocortisone. Mutagenicitystudieswi th hydrocortisonewere negative. Pregnancy: Teratogenic Effects. Pregnancy Category C:
Reproductionstudi es have beenperformed in rats and mice using oral doses of upto 100mglkgand IV doses upto 30 mglkg and have revealedno evidence of harm to thefetus asa result of ciprofloxacin. In rabbits, ciprol loxacin (30and100 mglkgoralty)producedgastrointestinal di stur bances resul ting in mat ernalweightlossand an increasedincidenceof abortion,but noteratogenicitywas observed ateither dose. After infraven ousadmi nistrat ionof doses upto20 mglkg, nomaternaltoxi citywas producedintherabbit , and noembryotoxi ci tyor ter atogenici ty was observed. Cort icoster oi ds are generall y teratogenic in laboratory ani mals when admi nistered systemically at rel ati vel y low dosage levels. The more potent corticosteroids have beenshown to be teratogenic after dermal applicationin laboratoryanimals. Animal reproducti on studies have not been conducted with CIPRO' HC OTIC. No adequate and well controlled studies have been performed In pregnant wome n. Caut ion should be exercise d when CIPRO' HCOTICis used by a pregnant woman. Nursing Mothers: Ciprofloxacin Is exc reted in humanmilkwith systemicuse. It is not knownwhether ciprofl oxa cin is excr etedin humanmi lk lollowingtopical oticadministrat ion. Because of the potentialfor serious adversereactionsin nursing infants, adecisi onshould bemadewhether to discont inuenur singor todiscontinuethedrug, Ia~ng into account theimport anceofthedrugto themother . Pediatric use: The safety and efficacy of CIPRO' HC OTIChave been established in pediatric patient s 2 years an d older (131 patient s) in adequate and welt-controlled clinical trials. Although no data are available on patients less than age 2 years, there are no known safety concerns or di fferences in the di seaseprocess inthispopulationwhich would preclude useofthis productin patients oneyear and ol der . See DOSAGE AND ADMINISTRATION. ADVERSE REACTIONS InPhase 3 clinical trial s, atotal of 564 patients weretreated with CIPRO' HCOTIC. Adverse events wi th at least remote rel ationship to treatmentincluded headache (1.2%) and pruritus (0.4%). The follow ing treatment-related adverse eventswereeach reportedinasi ngle patient:migrai ne, hypesthesia, paresthesi a, lungalder matitis, cough, rash, urti car ia, and alopecia. 
